SUBSCRIBE
SUBSCRIBE
News   Policy

Abbott Laboratories (JOBS) Faces New US Sales Probe, Depakote in Focus

November 9, 2009 | 
1 min read
Bookmark and Share

Reuters -- Federal officials are investigating how Abbott Laboratories Inc (ABT.N) has marketed the epilepsy drug Depakote, the company said on Friday, the latest U.S. probe of its sales practices.
Regulatory
Abbott Laboratories
MORE ON THIS TOPIC
Human kidney made out of lines. Medical Concept. 3D Rendering.
Kidney disease
Roche-Ionis’ RNA therapy reduces kidney disease marker, opening path to swift FDA nod
September 23, 2026
 · 
2 min read
 · 
Annalee Armstrong
FDA
Novo’s turnaround plan, weight loss wins, Ultragenyx’s Sanfilippo approval, IPO blitz
September 23, 2026
 · 
2 min read
 · 
Jef Akst
Illustration showing businessman trying to create his own road
FDA
Compass vows to press on with FDA application despite new trial request
September 22, 2026
 · 
3 min read
 · 
Annalee Armstrong
FDA
FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival
September 16, 2026
 · 
1 min read
 · 
Jef Akst